Dr David Simon Joins the Zrii Scientific Advisory Board
Draper, UT (PRWEB) September 2, 2009 -- Zrii, LLC (www.zrii.com) announced last week that Dr. David Simon will become the fourth member of the Zrii Scientific Advisory Board, a group consisting of award-winning Western doctors and world-renown Ayurvedic physicians and scholars. Current members of the Scientific Advisory Board include Dr. Thomas Yarema MD; Suhas Kshirsagar BAMS, M.D. (Ayurveda); and Daniel Rhoda D.A.S (Ayurveda).
"Our company has a special partnership with the Chopra Center [for Wellbeing™," states Bill Farley, Founder and CEO of Zrii. "Their endorsement is on both our products--Zrii, the Original Amalaki™, and our newly released weight management product, NutriiVeda™. I couldn't be more pleased to be working more closely with Dr. Simon."
Dr. David Simon is a board-certified neurologist and pioneer in the medical field. His personal mission is to facilitate the integration of complementary and conventional medicine in the 21st century. Dr. Simon is considered to be one of the nation's foremost authorities on effective and appropriate use of holistic healthcare practices, specifically Ayurveda the--5,000-year-old healing tradition of India. In addition to his prolific program development for the Chopra Center, Dr. Simon is the author of 11 world-renowned wellness books, many of which were co-authored with Deepak Chopra.
More information about the Scientific Advisory Board can be found at http://www.zrii.com/pages/company/sab.xhtml.
About the Company
Zrii, LLC, is an international wellness company that utilizes the direct selling industry to market an exclusive nutritional beverage and revolutionary weight management product. Based primarily on the Indian fruit known as amalaki, Zrii's products are fully endorsed by the prestigious Chopra Center for Wellbeing. Zrii has over 65,000 Independent Executives in the United States, Canada, Mexico, Israel, and Colombia who help individuals achieve better health and wealth. Founded in October 2007, Zrii achieved almost $45 million in revenue during its first year of business.